6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Struktur
1812890-23-5
CAS-Nr.
1812890-23-5
Englisch Name:
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
Synonyma:
Tofatinib Impurity 17;Tofacitinib Related Compound 23;Azilsartan medoxomil impurity319;Tofacitinib Hydrogenation Impurities;(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine;6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine;5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
CBNumber:
CB53143734
Summenformel:
C13H21N5
Molgewicht:
247.34
MOL-Datei:
1812890-23-5.mol

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Eigenschaften

Siedepunkt:
435.9±45.0 °C(Predicted)
Dichte
1.137±0.06 g/cm3(Predicted)
Löslichkeit
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
9.48±0.10(Predicted)
Farbe
Off-White to Pale Yellow

Sicherheit

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine is an intermediate (reagent) in the preparation of Tofacitinib analog compounds.

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 35)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58
Labnetwork lnc.
+86-27-50766799 +8618062016861
contact@labnetwork.com China 19994 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
ShenZhen H&D Pharmaceutical Technology Co., LTD
+86-0755-22677845 +86-13627253706
sale@hdimpurity.com China 3154 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
shiqingran@wzxchem.com China 3621 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4762 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 18018 56
Shanghai AECOM Biotechnology Co. , Ltd. 021-021-20956531 18116226605
sui@neosunpharm.com China 350 55
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50

  • 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
  • Tofacitinib Related Compound 23
  • 5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
  • Azilsartan medoxomil impurity319
  • Tofacitinib Hydrogenation Impurities
  • (6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine
  • Tofatinib Impurity 17
  • N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
  • 1812890-23-5
Copyright 2019 © ChemicalBook. All rights reserved